Best in Biotech 14 Nov 2023 10 biotech companies leading innovation in the Asia-Pacific region …Based in both Taiwan and the U.S., Acepodia is focused on transforming cancer treatment with first-in-class immune cell engagers that have enhanced and targeted potency thanks to the company’s Antibody-Cell… November 14, 2023 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Oct 2024 Six biotech companies advancing multiple sclerosis therapies …TG Therapeutics reported that, after five years of treatment with BRIUMVI, 92% of patients with relapsing multiple sclerosis were free from disability progression. Ublituximab is a monoclonal antibody that targets… October 24, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 5 Mar 2018 Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody that AstraZeneca dropped after failing two Phase III trials in asthma. LEO Pharma is taking… March 5, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases …be comparable to placebo, and there were no cases of amyloid-related imaging abnormalities-edema (ARIA-E) in the phase 2a main study. “UB-311 also elicited robust and durable anti-amyloid beta antibody responses… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Dec 2021 The Biggest European Biotech News of 2021 …French big pharma Sanofi acquired the UK firm Kymab for up to €1.2B. Kymab’s pipeline included a phase IIa-stage antibody drug for the treatment of the inflammatory skin condition atopic… December 22, 2021 - 10 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 16 Nov 2017 Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics …of particular interest to Dochez: “Using the person’s own immune system… targeting the tumor microenvironment with an antibody, or with a small molecule, or even with the other technologies like… November 16, 2017 - 6 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 12 Oct 2022 Novavax COVID-19 vaccine data supports homologous and heterologous boosting …a type of antibody) levels increased significantly relative to pre-boost levels, rising above the level correlated with 95% vaccine efficacy in a recent USG study. Neutralizing antibodies against the prototype… October 12, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 17 Apr 2017 Meet One of the Most Successful German Biotech Leaders Ever …looked like a disaster in the first place, created the opportunity to develop a bispecific T cell-engaging antibody that was in-licensed from inventors at Munich’s LMU. This antibody ultimately became… April 17, 2017 - 6 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2025 How biotech is improving the life of your cat …from human or canine drugs isn’t a durable option. If you give a cat a human or dog-like antibody, the cat’s immune system may attack it. So, companies build the… August 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 16 Jul 2025 Eight rare autoimmune diseases biotechs are fighting to treat …two candidates for Graves’ disease: batoclimab and IMVT-1402. In September 2024, the company reported positive phase 2a results from a clinical trial investigating the monoclonal antibody batoclimab in patients with… July 16, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 30 Aug 2017 German Scientists Publish New Mechanism of Action Against Alzheimer’s …developing a therapeutic antibody with a unique mode of action against Alzheimer’s, PBD-C06. The company announced yesterday the publication in the Journal of Biological Chemistry of the detailed binding mechanism… August 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Oct 2022 Merck contributing to Jacobio Pharma colorectal cancer clinical trial …treatment; combination therapy with SHP2 inhibitor, PD-1 monoclonal antibody and cetuximab. About Erbitux (cetuximab) Erbitux is an IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). As a monoclonal… October 13, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email